Prostate cancer

Over 1.3 million men were diagnosed with prostate cancer in 2018 making this malignancy the second most common in men.

Showing 1–9 of 81 results

EpiMelt MLH1 test assay

Homo sapiens mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), NM_000249

DNA Methylation Assay Kit for MLH1 based on MS-HRM. Includes controls

EpiMelt APC test assay

Homo sapiens adenomatous polyposis coli (APC), NM_001127511

DNA Methylation Assay Kit for APC, based on MS-HRM. Includes controls.

 

EpiMelt CDH1 test assay

Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), NM_004360

DNA Methylation Assay Kit for CDH1, based on MS-HRM. Includes controls

 

EpiMelt CDH13 test assay

Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), NM_001220492

DNA Methylation Assay Kit for CDH13, based on MS-HRM. Includes controls

 

EpiMelt TIMP3 test assay

Homo sapiens TIMP metallopeptidase inhibitor 3 (TIMP3), NM_000362

DNA Methylation Assay Kit for TIMP3, based on MS-HRM. Includes controls

 

EpiMelt GSTP1 test assay

Homo sapiens glutathione S-transferase pi 1 (GSTP1), NM_000852

DNA Methylation Assay Kit for GSTP1, based on MS-HRM. Includes controls

 

EpiMelt ATM test assay

Homo sapiens ataxia telangiectasia mutated (ATM), NM_000051

Approximate delivery time 4 weeks

EpiMelt PITX2 test assay

Homo sapiens paired-like homeodomain 2 (PITX2), NM_000325

DNA Methylation Assay Kit for PITX2, based on MS-HRM. Includes controls.